Abstract
SETTING:
Forty-six health centers in south Lima, Peru.
OBJECTIVE:
To assess the association between caregivers’ knowledge and perceptions around isoniazid preventive therapy (IPT) and whether their children complete IPT.
DESIGN:
We conducted a retrospective medical record review of children who initiated IPT during 2017–2018. We administered structured surveys to caregivers of the children about their knowledge about and perceptions of IPT. We used a modified Poisson regression to determine factors associated with IPT completion.
RESULTS:
We included 550 children, of whom 31% did not complete IPT. Independent factors associated with not completing IPT were low caregiver knowledge about TB and IPT (adjusted risk ratio [aRR] 1.41, 95% CI 1.06–1.78), low caregiver perception of the importance of IPT (aRR 1.76, 95% CI 1.30–2.39), low caregiver satisfaction with the health services (aRR 1.57, 95% CI 1.14–2.16), experience of adverse events (aRR 2.08, 95% CI 1.51–2.87), and living in a household with moderate or severe family dysfunction (aRR 1.53, 95% CI 1.07–2.19).
CONCLUSION:
IPT completion among children was associated with the knowledge and perceptions of their caregivers, as well as the experience of adverse events. To improve IPT completion among children, health care providers should prioritize education and counseling for caregivers, promote positive interpersonal relationships with them, and monitor adverse events.
Keywords: tuberculosis, preventive therapy, isoniazid, children, adolescents
Abstract
CONTEXTE :
Quarante-six centres de santé au Sud de Lima, Pérou.
OBJECTIF :
Evaluer l’association entre les connaissances et les perceptions relatives au traitement préventif par l’isoniazide (TPI) des responsables des enfants et le fait que leurs enfants aient achevé le TPI.
SCHÉMA :
Nous avons réalisé une revue rétrospective des dossiers médicaux des enfants qui ont démarré le TPI entre 2017 et 2018. Nous avons administré aux responsables des enfants des questionnaires structurés relatifs à leurs connaissances et perceptions du TPI. Nous avons utilisé une régression de Poisson modifiée afin de déterminer les facteurs associés à l’achèvement du TPI.
RÉSULTATS :
Nous avons inclus 500 enfants dont 31% n’ont pas achevé le TPI. Les facteurs indépendants associés au non achèvement étaient faibles connaissances relatives à la TB et au TPI (risque relatif ajusté [RRa] 1,41 ; IC 95% 1,06–1,78), faibles perception par les responsables de l’importance du TPI (RRa 1,76 ; IC 95% 1,30–2,39), faible taux de satisfaction des responsables par rapport aux services de santé (RRa 1,57 ; IC 95% 1,14–2,16), survenue d’effets secondaires (RR 2,08 ; IC 95% 1,51–2,87) et dysfonction familiale modérée ou grave (RRa 1,53 ; IC 95% 1,07–2,19).
CONCLUSION :
L’achèvement du TPI chez les enfants a été associé aux connaissances et perceptions de leurs responsables, ainsi qu’à la survenue d’effets secondaires. Pour améliorer l’achèvement du TPI chez les enfants, les prestataires de soins de santé devraient accorder la priorité à l’éducation des responsables, promouvoir des relations inter personnelles positives avec eux et surveiller les effets secondaires.
Children in close contact with adults who have TB are at high risk of being infected themselves, and if TB disease develops, they can develop fatal disseminated forms such as miliary TB and TB meningitis.1,2 The WHO recommends that household contacts of TB patients receive preventive therapy.3 The most common regimen used for preventive therapy in low- and middle-income countries is 6 months of daily isoniazid (isoniazid preventive therapy, IPT). It is estimated that only 33% of young children (age <5 years) worldwide who were household contacts of TB patients received preventive therapy in 2019; the number who completed this treatment was not reported to the WHO.4
Studies identifying factors associated with preventive therapy completion under programmatic conditions have been published from diverse settings. In South Africa, more children completed preventive therapy when treatment was supervised by health care workers or community treatment supporters, and when a shorter treatment regimen was used.5 In India, IPT completion was better in rural clinics than in urban clinics.6 In Brazil, IPT non-completion was associated with the human development index of the patient’s residence, having contact with a TB patient who had not completed treatment,7 and low socioeconomic status.8 In Peru, IPT completion has been associated with receiving a tuberculin skin test, TB treatment completion of the index patient, and health facility characteristics.9
Many of these studies have identified associations between IPT completion and demographic or clinical characteristics of the child or the index patient. However, to inform programmatic improvement, it is important to also assess factors that health care providers can modify while a person is in care. For example, providers can potentially affect patients’ perceptions of the importance of treatment through education or counseling. For children, IPT is likely to depend on the caregiver, but relatively few studies have focused on caregivers’ perceptions or knowledge of IPT.10,11 Moreover, the association between caregivers’ perceptions and knowledge and whether their children complete IPT is unclear. One mixed methods study found no quantitative association between IPT completion and caregiver knowledge and perceptions, and yet found these to be important facilitators of adherence in qualitative analysis.12 This qualitative evidence that caregiver perceptions affect IPT completion is corroborated by other research,13 but quantitative evidence of an association is lacking. To address this knowledge gap, we conducted a study in Lima, Peru, to assess the association between caregivers’ knowledge and perceptions of IPT and whether their children completed IPT.
METHODS
Study design
We conducted a cross-sectional study to measure the association between the knowledge and perceptions of caregivers and whether their children completed IPT. To adjust for other factors that could affect IPT completion, we used the WHO conceptual framework for medication adherence.14
Study population
The Directorate of the Integrated Health Networks of South Lima (Dirección de Redes Integradas de Salud [DIRIS] Lima Sur) manages 136 health facilities in 13 districts in the south of Lima, comprising a catchment population of 1.86 million. For this study, we enrolled caregivers whose children had received IPT in 46 of the health centers that reported the highest TB caseloads in 2017, representing 80% of the total TB cases in the DIRIS Lima Sur. In Peru, contacts of patients with pulmonary TB should receive IPT after ruling out TB disease if they are 1) aged <5 years or 2) 5–19 years and have a TST induration of ⩾10 mm.15 All people living with HIV should also receive IPT, but because of the low HIV prevalence in the general population (0.3% among adults aged 15–49 years), contacts are not routinely tested for HIV.16
We reviewed medical records to identify children aged <19 years who initiated IPT during 2017–2018. We excluded children who had moved outside the jurisdiction of the our health facility, who had been diagnosed with TB during IPT, or for whom IPT had been suspended by the managing physician. We recruited the caregivers of eligible children during May–August 2019. Caregivers were eligible for inclusion if they were ⩾18 years old and were the family member who had been in charge of managing the child’s IPT.
Data collection
Data were collected using a structured survey administered to caregivers in their homes. The outcome of the analysis was whether the child completed 24 weeks of IPT. Study staff knew the IPT outcome recorded on the contact’s medical record at the time of the survey. They were trained to ask standardized questions to all caregivers about whether their child had completed IPT and how many months the child had been on treatment. If the caregiver said that the child had completed IPT but the medical record did not, the caregiver was asked for the approximate completion date and health facility (in case the child had been transferred during treatment). This information was then verified in the isoniazid dispensing records. If the medical records said that the child had completed IPT but the caregiver said that they had not, then the caregiver’s account was believed.
We evaluated factors affecting IPT completion based on the WHO framework for medication adherence.14 Our principal predictors of interest were in the domain of knowledge, attitudes, and perceptions. Specifically, we assessed caregivers’ knowledge about TB and IPT and their perception of the importance of IPT. In the domain of health system-related factors, we assessed care-givers’ satisfaction with the health care staff who managed IPT. In the domain of social and economic factors, we considered the age and sex of the child; the age, sex, education level, and occupation of the caregiver; and family function, as measured by the Family APGAR (adaptation, partnership, growth, affection, and resolve) Questionnaire.17 In the domain of factors related to treatment, we considered whether the child had any adverse event during IPT, as reported by the caregiver and verified in the medical records.
We defined a low level of knowledge as correctly answering <6 of the 8 true-false questions about TB and IPT based on information in the Peru national TB guidelines.15 To assess caregivers’ perception of the importance of IPT and their satisfaction with health care staff, we treated survey responses as a Likert scale and calculated the average response over the two questions in each category. Low perceived importance of IPT was defined as an average score of <2 out of a possible 3, and low satisfaction with health services was defined as an average score of <3 out of a possible 4. We defined moderate or severe dysfunction as corresponding to scores indicating low or moderate satisfaction with family function on the Family APGAR Questionnaire.17 The questionnaire was validated by TB experts and pilot tested with 15 participants.
Statistical analysis
To assess factors associated with IPT completion, we calculated risk ratios (RRs) with 95% confidence intervals (CIs) using modified Poisson regression with generalized estimating equations to account for correlation among children in the same household. In multivariable analysis, we included a priori caregiver knowledge and caregiver perception of IPT importance. We included other variables with a P value of ⩽0.15 in bivariate analysis. We limited multivariable analysis to children with complete data. Statistical analysis was performed using SAS v9.4 (SAS Institute, Cary, NC, USA).
Ethics
This study was approved by the ethics committees of the Hospital Nacional Dos de Mayo and the DIRIS Lima Sur, Lima, Peru. Written informed consent was provided by caregivers.
RESULTS
We identified 592 children who initiated IPT during 2017–2018, and we enrolled caregivers of 550 (93%) of these children. We excluded 39 children whose families had moved outside the jurisdiction of the health facility, 1 child who developed TB disease, and 2 children for whom IPT was suspended. The 550 children included lived in 367 households; 35% of households had more than one child. We administered surveys to 367 caregivers (Table 1).
TABLE 1.
Social and demographic characteristics of caregivers and contacts
Characteristics | n | % |
---|---|---|
Caregivers (n = 367) | ||
Age, years | ||
18–30 | 164 | 45 |
31–45 | 129 | 35 |
⩾46 | 74 | 20 |
Sex | ||
Male | 69 | 19 |
Female | 298 | 81 |
Is the caregiver the TB patient? | ||
Yes | 173 | 47 |
No | 194 | 53 |
Highest level of education attained | ||
Primary or lower | 39 | 11 |
Secondary | 241 | 66 |
Post-secondary | 87 | 24 |
Contacts (n = 550) | ||
Age, years | ||
0–4 | 358 | 65 |
5–9 | 117 | 22 |
10–15 | 62 | 11 |
16–18 | 13 | 2 |
Sex | ||
Male | 311 | 57 |
Female | 239 | 43 |
In total, 380 (69%) of the children completed IPT. These included 45 (8%) children whose medical records indicated that they did not complete IPT; caregiver’s accounts of IPT completion were verified from isoniazid dispensing records and at health facilities to which children had been transferred. Adverse events (AEs) were reported by caregivers and verified in medical records for 34 (6%) children (Table 2).
TABLE 2.
AEs reported by caregivers among children during IPT (n = 550) *
Adverse event | n | % |
---|---|---|
No AEs reported | 516 | 94 |
Stomach pain | 16 | 3 |
Nausea | 13 | 2 |
Loss of appetite | 10 | 2 |
Vomiting | 9 | 2 |
Rash | 1 | <1 |
Other | 3 | 1 |
*Caregivers were asked specifically about five AEs. Other events reported were insomnia, constipation, and diarrhea.
AE = adverse event; IPT = isoniazid preventive therapy.
TB and IPT knowledge among caregivers
Over 90% of caregivers knew that TB is transmitted through the air (97%), and that transmission can be prevented by good ventilation (95%) and avoiding being close to a person with TB who is coughing (91%) (Table 3). However, less than half of caregivers knew that TB cannot be transmitted by sharing utensils (42%), and that having TB patients use separate dishes and utensils is not an appropriate TB preventive measure (38%). The median number of knowledge questions answered correctly by caregivers was 6 (interquartile range [IQR] 5–7) out of 8.
TABLE 3.
Caregiver knowledge about TB and IPT (n = 367)
Questions | Caregivers who responded correctly | |
---|---|---|
n | % | |
Knowledge about TB transmission | ||
Can TB be transmitted through the air when a person coughs or sneezes? | 354 | 97 |
Can TB can be transmitted by sharing utensils? | 152 | 42 |
Can TB can be transmitted by touching a person with TB? | 297 | 81 |
Knowledge about TB preventive measures | ||
Can family members avoid getting TB by maintaining well-ventilated rooms? | 352 | 96 |
Can family members avoid getting TB by maintaining physical distance from the person who has TB? | 252 | 69 |
Can family members avoid getting TB by not being close to the person with TB when they cough or sneeze? | 332 | 91 |
Can family members avoid getting TB by keeping separate plates and utensils for the person with TB? | 137 | 38 |
Knowledge about IPT | ||
What could happen if a child does not take IPT?* | 321 | 88 |
*Responses mentioning that the child could fall sick with TB were considered correct.
Perceptions of IPT importance and IPT services
Only 195 (53%) caregivers believed that it was very important for their child to complete IPT (Table 4). In addition, 169 (46%) caregivers said that before initiating IPT, they had felt that it was very likely that their child would develop TB, compared to 67 (18%) who had felt it was unlikely (Table 4). The median score for perceived importance of IPT was 2.5 (IQR 2–3) out of 3 points. With respect to their experiences with the health services, 332 (90%) caregivers felt satisfied or very satisfied with the attention received, and 348 (95%) felt the staff were friendly and courteous. The median score for health system satisfaction was 3.5 (IQR 3–4) out of 4 points.
TABLE 4.
Caregiver responses to questions about importance of IPT and satisfaction with health services (n = 367)
Questions | Caregiver responses | |
---|---|---|
n | % | |
Perceptions about importance of IPT | ||
How important did you feel it was for your child to complete IPT? | ||
Not important or not very important | 23 | 6 |
Somewhat important | 148 | 40 |
Very important | 195 | 53 |
No response | 1 | <1 |
Before starting treatment, how likely did you think it was that your child would develop TB? | ||
Not likely or not very likely | 67 | 18 |
Somewhat likely | 129 | 35 |
Very likely | 169 | 46 |
No response | 2 | 1 |
Satisfaction with health services | ||
How would you rate your satisfaction with the attention you received from the health facility staff? | ||
Very unsatisfied | 10 | 3 |
Unsatisfied | 23 | 6 |
Satisfied | 196 | 53 |
Very satisfied | 136 | 37 |
No response | 1 | <1 |
How would you rate the friendliness and courtesy of the person who gave you the isoniazid? | ||
Very poor | 5 | 1 |
Poor | 11 | 3 |
Good | 169 | 46 |
Very good | 179 | 49 |
No response | 3 | 1 |
IPT = isoniazid preventive therapy.
Risk factors for not completing IPT
In bivariate analysis, non-completion of IPT was associated with low caregiver knowledge, low caregiver perception of IPT importance, and low caregiver satisfaction with health services, the caregiver not being the index patient and moderate or severe family dysfunction (Table 5). We included 520 children with complete data in the multivariable analysis. Low caregiver knowledge about TB and IPT (adjusted risk ratio [aRR] 1.41, 95% CI 1.06–1.78), low caregiver perception of IPT importance (aRR 1.76, 95% CI 1.30–2.39), and low caregiver satisfaction with health services (aRR 1.57, 95% CI 1.14–2.16) remained independently associated with IPT non-completion. In addition, children who experienced AEs were twice as likely not to complete IPT (aRR 2.08, 95% CI 1.51–2.87). Moderate or severe family dysfunction also remained independently associated with IPT non-completion (aRR 1.53, 95% CI 1.07–2.19).
TABLE 5.
Bivariate and multivariable associations between caregiver characteristics and IPT completion in child contacts
Characteristic | Bivariate analysis | Multivariable analysis | |||||
---|---|---|---|---|---|---|---|
RR | 95% CI | P value | aRR | 95% CI | P value | ||
Caregiver TB knowledge | High | Reference | |||||
Low | 1.71 | 1.22–2.61 | 0.003 | 1.41 | 1.06–1.78 | 0.017 | |
Caregiver perception of IPT importance | High | Reference | |||||
Low | 2.11 | 1.57–2.84 | <0.001 | 1.76 | 1.30–2.39 | <0.001 | |
Caregiver satisfaction with health services | High | Reference | |||||
Low | 2.00 | 1.46–2.74 | <0.001 | 1.57 | 1.14–2.16 | 0.005 | |
Caregiver sex | Female | Reference | |||||
Male | 1.25 | 0.89–1.74 | 0.197 | ||||
Caregiver age, years | 18–30 | Reference | |||||
31–45 | 1.07 | 0.75–1.55 | 0.682 | ||||
⩾46 | 0.87 | 0.62–1.22 | 0.409 | ||||
Caregiver is the TB patient | No | Reference | |||||
Yes | 1.41 | 1.05–1.91 | 0.025 | 1.22 | 0.92–1.61 | 0.166 | |
Caregiver highest education level | More than secondary | Reference | |||||
Secondary or below | 1.25 | 0.86–1.82 | 0.233 | ||||
Caregiver works | No | Reference | |||||
Yes | 1.32 | 0.98–1.80 | 0.067 | 1.23 | 0.93–1.64 | 0.149 | |
Caregiver perception of family function | Functional | Reference | |||||
Moderate or severe dysfunction | 1.78 | 1.22–2.61 | 0.003 | 1.53 | 1.07–2.19 | 0.018 | |
Child contact sex | Female | Reference | |||||
Male | 1.11 | 0.96–1.28 | 0.154 | ||||
Child contact age, years | 0–4 | Reference | |||||
5–9 | 0.88 | 0.75–1.04 | 0.136 | 0.93 | 0.82–1.06 | 0.282 | |
10–18 | 0.97 | 0.82–1.14 | 0.720 | 0.99 | 0.83–1.18 | 0.881 | |
Child experienced adverse event | No | Reference | |||||
Yes | 2.36 | 1.75–3.17 | <0.001 | 2.08 | 1.51–2.87 | <0.001 |
IPT = isoniazid preventive therapy; RR = risk ratio, CI = confidence interval, aRR = adjusted RR.
DISCUSSION
In this study, IPT completion in child contacts of TB patients was associated with their caregivers’ knowledge about TB and perceptions of the importance of IPT. IPT completion was also associated with the occurrence of AEs, caregivers’ satisfaction with health services, and family environment. Our findings contrast with previous studies that did not find significant associations between caregivers’ knowledge and their children’s IPT completion.12,18 However, our results are consistent with studies of adult patients, which have found that adults are less likely to complete IPT if they lack knowledge about its purpose19 or do not believe that they are at risk for TB.20 It is possible that the relationship between caregivers’ knowledge and perceptions and their willingness or ability to support children’s treatment completion may vary across settings. Nevertheless, our findings highlight the importance of efforts on the part of the health system to educate, counsel, and build positive relationships with caregivers of children receiving IPT.
We found that the majority of caregivers were satisfied with the services they received from the health system; however, dissatisfied caregivers were more likely to report that their children did not complete IPT. Because the survey was administered after children had already stopped IPT, we cannot tell whether dissatisfaction was a cause of IPT non-completion, or whether dissatisfaction resulted from a situation that contributed to IPT non-completion (e.g., AEs that went unattended by the health system). However, previous studies have reported that positive support from health care providers is a facilitator of IPT adherence12 and that negative relationships between caregivers and health care providers can impede adherence.21 Together, this evidence suggests that fostering trusting relationships between caregivers and health care providers could promote IPT adherence.
Few children in our study experienced AEs, consistent with observations from international clinical trials22 and routine practice in Peru.23 However, caregiver-reported AEs was a risk factor for not completing IPT. This finding is consistent with other studies that have used interviews to identify AEs,24,25 but not with some studies based on treatment registers.7,26 Studies based on recall may be subject to bias if patients who struggled to complete treatment are more likely to recall experiencing AEs; on the other hand, studies based on treatment registers may be subject to the opposite bias if patients who remain in care are more likely to have their AEs recorded by the health system. Notwithstanding these limitations, the results of our study and other interview-based studies suggests that concern over AEs may present a challenge to IPT completion, and therefore, active monitoring of AEs is important for supporting adherence.
Our observation that family function was associated with IPT completion is consistent with studies from other disease areas, which have found that the family function is associated with adherence to chronic disease treatment in children.27 Family support has also been shown to be associated with adherence to treatment for TB disease in adults.28 While the mechanisms may be similar, it is unknown how exactly the family environment affects IPT completion in child contacts, and future studies could help increase understanding in this area.
In Peru, health care providers train caregivers to supervise IPT for all contacts; however, in practice, caregivers may play a more limited role in supervising IPT for adolescents compared to younger children. Given their greater independence, adolescents may have distinct needs for treatment support.29 Older adolescents have been shown to be at higher risk for incomplete treatment for TB disease than younger children.30,31 There is little literature on the needs of adolescent contacts receiving preventive therapy. Thus, it is a limitation of our study that we only assessed the knowledge and perceptions of caregivers. Future research should also assess how knowledge and perceptions among adolescent contacts affect preventive therapy completion.
Our study is subject to several limitations. Caregiver responses could have been affected by incomplete recall or recall bias. However, we were able to verify some information, such as IPT completion and the occurrence of AEs, from medical records. Also, because of the timing of the survey, the knowledge and perceptions reported during the survey may not reflect the situation while the children were taking IPT, and it is difficult to speculate on possible causal mechanisms. Social desirability bias could have made caregivers reluctant to express negative opinions about the importance of IPT or satisfaction with health services. We attempted to mitigate this risk by administering the surveys in participants’ homes, ensuring confidentiality, and training the survey administrators to ask questions in a standardized manner.
CONCLUSION
Our findings suggest that health systems should prioritize education and counseling among caregivers of child contacts receiving IPT. Education and counseling could help caregivers better understand the importance of IPT in preventing TB disease and promote positive relationships between families affected by TB and the health system. Increased understanding and positive relationships could in turn support IPT adherence and the monitoring of AEs. Ultimately, increasing the effective use of IPT will help reduce TB morbidity and mortality among children.
ACKNOWLEDGEMENTS
This study was funded by Universidad Nacional Mayor de San Marcos, Lima, Peru. CMY was supported by the Ronda Stryker and William Johnston Fund at Harvard Medical School, Boston, MA, USA.
Footnotes
Conflict of interests: none declared.
References
- 1.Starke JR, et al. Interferon-gamma release assays for diagnosis of tuberculosis infection and disease in children. Pediatrics. 2014;134(6):e1763–1773. doi: 10.1542/peds.2014-2983. [DOI] [PubMed] [Google Scholar]
- 2.Triasih R, et al. Risk of infection and disease with Mycobacterium tuberculosis among children identified through prospective community-based contact screening in Indonesia. Trop Med Int Health. 2015;20(6):737–743. doi: 10.1111/tmi.12484. [DOI] [PubMed] [Google Scholar]
- 3.World Health Organization Global tuberculosis report, 2020. Geneva, Switzerland: WHO; 2020. https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf [Google Scholar]
- 4.World Health Organization WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment. Geneva, Switzerland: WHO; 2020. https://www.who.int/publications-detail-redirect/who-consolidated-guidelines-on-tuberculosis-module-1-prevention-tuberculosis-preventive-treatment [PubMed] [Google Scholar]
- 5.Van Zyl S et al. Adherence to anti-tuberculosis chemoprophylaxis and treatment in children. Int J Tuberc Lung Dis. 2006;10(1):13–18. [PubMed] [Google Scholar]
- 6.Rekha B, et al. Improving screening and chemoprophylaxis among child contacts in India’s RNTCP: a pilot study. Int J Tuberc Lung Dis. 2013;17(2):163–168. doi: 10.5588/ijtld.12.0415. [DOI] [PubMed] [Google Scholar]
- 7.Mendonça AMC, et al. Abandonment of treatment for latent tuberculosis infection and socioeconomic factors in children and adolescents: Rio De Janeiro, Brazil. PLoS One. 2016;11(5):1–12. doi: 10.1371/journal.pone.0154843. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Barbosa Silva AP et al. Non-completion of latent tuberculous infection treatment among children in Rio de Janeiro State, Brazil. Int J Tuberc Lung Dis. 2016;20(4):479–486. doi: 10.5588/ijtld.15.0609. [DOI] [PubMed] [Google Scholar]
- 9.Otero L, et al. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data. Trop Med Int Health. 2020;25(3):346–356. doi: 10.1111/tmi.13350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Chacón A, Alarcón E, López L. Factores asociados al cumplimiento de la terapia preventiva con isoniacida en niños en Quito, Ecuador (2014–2016 y 2018) Rev Panam Salud Pública. 2019;43(1):1–8. doi: 10.26633/RPSP.2019.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Garie KT, Yassin MA, Cuevas LE. Lack of adherence to isoniazid chemoprophylaxis in children in contact with adults with tuberculosis in Southern Ethiopia. PLoS One. 2011;6(11):e26452. doi: 10.1371/journal.pone.0026452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Birungi FM, et al. Adherence to isoniazid preventive therapy among child contacts in Rwanda: a mixed-methods study. PLoS One. 2019;14(2):1–16. doi: 10.1371/journal.pone.0211934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Rutherford ME, et al. Adherence to isoniazid preventive therapy in Indonesian children: A quantitative and qualitative investigation. BMC Res Notes. 2012;5:7. doi: 10.1186/1756-0500-5-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.World Health Organization Adherence to long-term therapies: evidence for action. Geneva, Switzerland: WHO; 2003. https://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf [Google Scholar]
- 15.Ministerio de Salud Norma técnica de salud para la atención integral de las personas afectadas por tuberculosis. Lima, Peru: Ministerio de Salud; 2013. http://www.tuberculosis.minsa.gob.pe/newtb/archivos/norma_tecnica.pdf [Google Scholar]
- 16.UNAIDS Geneva, Switzerland: UNAIDS; 2019. Country factsheets: Peru 2019.https://www.unaids.org/es/regionscountries/countries/peru [Google Scholar]
- 17.Suarez Cuba MA, Alcalá Espinoza M. APGAR familiar: una herramienta para detectar disfución familiar. Rev Médica Paz. 2014;20(1):53–57. [Google Scholar]
- 18.Silva APB, et al. Non-completion of latent tuberculous infection treatment among children in Rio de Janeiro State, Brazil. Int J Tuberc Lung Dis. 2016;20(4):479–486. doi: 10.5588/ijtld.15.0609. [DOI] [PubMed] [Google Scholar]
- 19.Ambrona de Marcos V et al. Compliance of latent tuberculosis infection treatment in a cohort of TB contacts. Rev Esp Salud Publica. 2018;92:e201808057. [PMC free article] [PubMed] [Google Scholar]
- 20.Shieh FK, et al. Predicting non-completion of treatment for latent tuberculous infection: a prospective survey. Am J Respir Crit Care Med. 2006;174(6):717–721. doi: 10.1164/rccm.200510-1667OC. [DOI] [PubMed] [Google Scholar]
- 21.Szkwarko D, et al. Child contact management in high tuberculosis burden countries: A mixed-methods systematic review. PLoS One. 2017;12(8):e0182185. doi: 10.1371/journal.pone.0182185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Diallo T, et al. Safety and side effects of rifampin versus isoniazid in children. N Engl J Med. 2018;379(5):454–463. doi: 10.1056/NEJMoa1714284. [DOI] [PubMed] [Google Scholar]
- 23.Yuen CM, et al. Tuberculosis household accompaniment to improve the contact management cascade: a prospective cohort study. PLoS One. 2019;14(5):e0217104. doi: 10.1371/journal.pone.0217104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Silva AR da, Sousa AI, Sant’Anna CC. Barriers in the treatment of latent tuberculosis infection (LTBI) in children: a case study. Esc Anna Nery. 2014;18(3):386–391. [Google Scholar]
- 25.Chang S-H, et al. Factors associated with failure to complete isoniazid therapy for latent tuberculosis infection in children and adolescents. J Infect Public Health. 2014;7(2):145–152. doi: 10.1016/j.jiph.2013.11.001. [DOI] [PubMed] [Google Scholar]
- 26.Venturini E, et al. Latent tuberculosis treatment compliance in children: a 10-year experience. Pediatr Infect Dis J. 2018;37(6):617. doi: 10.1097/INF.0000000000001857. [DOI] [PubMed] [Google Scholar]
- 27.Psihogios AM, et al. Family functioning and medical adherence across children and adolescents with chronic health conditions: a meta-analysis. J Pediatr Psychol. 2019;44(1):84–97. doi: 10.1093/jpepsy/jsy044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Cedeño Ugalde MA et al. Apoyo familiar en la adherencia al tratamiento de pacientes con tuberculosis. Dominio Las Cienc. 2018;5(1):54–68. [Google Scholar]
- 29.Snow K, et al. Adolescent tuberculosis. Lancet Child Adolesc Health. 2020;4(1):68–79. doi: 10.1016/S2352-4642(19)30337-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Mulongeni P, et al. HIV prevalence and determinants of loss-to-follow-up in adolescents and young adults with tuberculosis in Cape Town. PLoS One. 2019;14(2):e0210937. doi: 10.1371/journal.pone.0210937. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Snow K, et al. Tuberculosis in adolescents and young adults: epidemiology and treatment outcomes in the Western Cape. Int J Tuberc Lung Dis. 2017;21(6):651–657. doi: 10.5588/ijtld.16.0866. [DOI] [PubMed] [Google Scholar]